XBP Europe Holdings, Inc. Reports First Quarter 2025 Results
First Quarter 2025 Highlights
- Revenue of
$37.7 million , a decrease of 1.2% year-over-year and increase of 5.7% sequentially - Gross margin of 30.1%, a 380 bps increase year-over-year and 190 bps increase sequentially
- Adjusted EBITDA of
$3.7 million , an increase of 25.6% year-over-year and decrease of 16.1% sequentially
“Our strong momentum continued into 2025, reflected by growing revenue, gross margin, and Adjusted EBITDA. We saw revenue growth for the third straight quarter, along with gross margin expansion on a year-over-year and sequential basis, driven by expanded use of AI technology and improved operational leverage,” said
First Quarter Highlights
- Revenue: Total Revenue was
$37.7 million , a decrease of 1.2% year-over-year and an increase of 5.7% sequentially.- Bills & Payments segment revenue was
$26.3 million , a decline of 1.2% year-over-year and an increase of 1.8% sequentially. - Technology segment revenue was
$11.4 million , a decrease of 1.0% year-over-year and an increase of 16% sequentially.
- Bills & Payments segment revenue was
- Operating Loss: Operating Loss was
$1.8 million compared to Operating Profit of$1.3 million a year ago and$1.0 million in the 4Q 2024. The decline was primarily driven by the recognition of$3.8 million of non-cash stock-based compensation due to accelerated vesting of RSUs and Options. When adjusted for this item, our Operating Profit was$2.0 million in the quarter, an improvement of$0.7 million year-over-year and$1.0 million sequentially, driven primarily by higher gross profit.
- Net Loss: Net loss from continuing operations was
$3.9 million . Adjusting for the previously mentioned non-cash stock-based compensation expense, our net loss from continuing operations was$0 million , compared with a net loss from continuing operations of$0.9 million a year ago and$0.2 million in the fourth quarter 2024.
- Adjusted EBITDA(1): Adjusted EBITDA from Continuing Operations was
$3.7 million , an increase of$0.8 million or 25.5% year-over-year. Adjusted EBITDA margin was 9.8%, an increase of 210 basis points year-over-year.
- Adequate Liquidity: The Company’s cash and cash equivalents totaled
$9.7 million as ofMarch 31, 2025 .
Pending Acquisition: As announced on
Below is the note referenced above:
(1) Adjusted EBITDA is a non-GAAP measure. A reconciliation of Adjusted EBITDA is attached to this release.
Supplemental Investor Presentation
An investor presentation relating to our first quarter 2025 performance is available at investors.xbpeurope.com. This information has also been furnished to the
About Non-GAAP Financial Measures
This press release includes constant currency, EBITDA, and Adjusted EBITDA, each of which is a financial measure that is not prepared in accordance with
The Company’s board of directors and management use these measures to evaluate the Company’s performance on a consistent basis across periods by excluding effects of the Company’s capital structure (such as varying debt levels, interest expense, and transaction costs from the
The constant currency presentation excludes the impact of fluctuations in foreign currency exchange rates. We calculate constant currency revenue and Adjusted EBITDA on a constant currency basis by converting our current-period local currency financial results using the exchange rates from the corresponding prior-period and compare these adjusted amounts to our corresponding prior period reported results.
The Company does not consider these non-GAAP measures in isolation or as an alternative to liquidity or financial measures determined in accordance with GAAP. A limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures and therefore the basis of presentation for these measures may not be comparable to similarly-titled measures used by other companies. These non-GAAP financial measures are not required to be uniformly applied, are not audited and should not be considered in isolation or as substitutes for results prepared in accordance with GAAP, and their presentation may not be comparable to similar measures used by other companies. Net loss is the GAAP measure most directly comparable to the non-GAAP measures presented here. For a reconciliation of the comparable GAAP measures to these non-GAAP financial measures, see the schedules attached to this release.
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding future events, estimated or anticipated future results and benefits, future opportunities for
About
For more
And please follow us on social:
X: https://X.com/XBPEurope
Facebook: https://www.facebook.com/XBPEurope/
Instagram: https://www.instagram.com/xbp_europe/
LinkedIn: https://www.linkedin.com/company/xbp-europe/
The information posted on
Condensed Consolidated Balance Sheets As of (in thousands of (Unaudited) |
|||||||
| 2025 | 2024 | ||||||
| ASSETS | |||||||
| Current assets | |||||||
| Cash and cash equivalents | $ | 9,681 | $ | 12,099 | |||
| Accounts receivable, net of allowance for credit losses of |
26,928 | 19,810 | |||||
| Inventories, net | 3,650 | 3,823 | |||||
| Prepaid expenses and other current assets | 5,756 | 4,228 | |||||
| Current assets held for sale | 1,526 | 1,378 | |||||
| Total current assets | 47,541 | 41,338 | |||||
| Property, plant and equipment, net of accumulated depreciation of |
12,223 | 11,272 | |||||
| Operating lease right-of-use assets, net | 4,861 | 4,805 | |||||
| 22,656 | 21,666 | ||||||
| Intangible assets, net | 1,173 | 1,121 | |||||
| Deferred income tax assets | 7,101 | 7,026 | |||||
| Long term notes receivable | 2,280 | — | |||||
| Other noncurrent assets | 1,142 | 817 | |||||
| Total assets | $ | 98,977 | $ | 88,045 | |||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
| LIABILITIES | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 13,507 | $ | 12,553 | |||
| Related party payables | 4,544 | 5,443 | |||||
| Accrued liabilities | 25,015 | 17,993 | |||||
| Accrued compensation and benefits | 17,951 | 16,482 | |||||
| Customer deposits | 328 | 277 | |||||
| Deferred revenue | 7,419 | 6,870 | |||||
| Current portion of finance lease liabilities | 4 | 12 | |||||
| Current portion of operating lease liabilities | 1,826 | 1,734 | |||||
| Current portion of long-term debts | 5,443 | 4,958 | |||||
| Current liabilities held for sale | 1,761 | 2,443 | |||||
| Total current liabilities | 77,798 | 68,765 | |||||
| Related party notes payable | 1,512 | 1,451 | |||||
| Long-term debt, net of current maturities | 24,289 | 23,966 | |||||
| Pension liabilities | 10,862 | 10,339 | |||||
| Operating lease liabilities, net of current portion | 3,227 | 3,271 | |||||
| Other long-term liabilities | 1,677 | 1,599 | |||||
| Total liabilities | $ | 119,365 | $ | 109,391 | |||
| Commitments and Contingencies (Note 13) | |||||||
| STOCKHOLDERS’ DEFICIT | |||||||
| Preferred stock, par value of |
— | — | |||||
| Common Stock, par value of |
36 | 30 | |||||
| Additional paid in capital | 7,494 | 1,611 | |||||
| Accumulated deficit | (28,055) | (23,705) | |||||
| Accumulated other comprehensive loss: | |||||||
| Foreign currency translation adjustment | (102) | 474 | |||||
| Unrealized pension actuarial gains, net of tax | 239 | 244 | |||||
| Total accumulated other comprehensive loss | 137 | 718 | |||||
| Total stockholders’ deficit | (20,388) | (21,346) | |||||
| Total liabilities and stockholders’ deficit | $ | 98,977 | $ | 88,045 | |||
Condensed Consolidated Statements of Operations For the three months ended (in thousands of United States dollars except share and per share amounts) (Unaudited) |
|||||||
| Three months ended |
|||||||
| 2025 | 2024 |
||||||
| Revenue, net | $ | 37,531 | $ | 38,047 | |||
| Related party revenue, net | 142 | 66 | |||||
| Cost of revenue (exclusive of depreciation and amortization) | 26,309 | 28,062 | |||||
| Related party cost of revenue | 9 | 18 | |||||
| Selling, general and administrative expenses (exclusive of depreciation and amortization) | 10,953 | 6,968 | |||||
| Related party expense | 1,562 | 926 | |||||
| Depreciation and amortization | 627 | 808 | |||||
| Operating profit (loss) | $ | (1,787) | 1,331 | ||||
| Other expense (income), net | |||||||
| Interest expense, net | 1,721 | 1,417 | |||||
| Related party interest expense, net | 23 | 19 | |||||
| Foreign exchange losses, net | (71) | 753 | |||||
| Changes in fair value of warrant liability | 2 | (37) | |||||
| Pension income, net | (369) | (423) | |||||
| Net loss before income taxes | $ | (3,093) | (398) | ||||
| Income tax expense | 762 | 460 | |||||
| Net loss from continuing operations | $ | (3,855) | (858) | ||||
| Net loss from discontinued operations, net of income taxes | (495) | (1,350) | |||||
| Net loss | $ | (4,350) | $ | (2,208) | |||
| Loss per share: | |||||||
| Basic and diluted - continuing operations | $ | (0.12) | $ | (0.03) | |||
| Basic and diluted - discontinued operations | (0.02) | (0.04) | |||||
| Basic and diluted | $ | (0.14) | $ | (0.07) | |||
Condensed Consolidated Statements of Cash Flows For the three months ended (in thousands of (Unaudited) |
|||||||
| Three months ended |
|||||||
| 2025 | 2024 | ||||||
| Cash flows from operating activities | |||||||
| Net loss | $ | (4,350) | $ | (2,208) | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Depreciation | 542 | 776 | |||||
| Amortization of intangible assets | 117 | 181 | |||||
| Debt issuance cost amortization | 105 | — | |||||
| Credit loss expense | (274) | 217 | |||||
| Changes in fair value of warrant liability | 2 | (37) | |||||
| Stock-based compensation expense | 3,587 | — | |||||
| Unrealized foreign currency losses (gains) | (546) | 759 | |||||
| Change in deferred income taxes | 156 | 44 | |||||
| Change in operating assets and liabilities | |||||||
| Accounts receivable | (5,816) | (1,160) | |||||
| Inventories | 285 | (102) | |||||
| Prepaid expense and other assets | (1,547) | (1,342) | |||||
| Accounts payable | 377 | 1,463 | |||||
| Related party payables | (267) | (1,711) | |||||
| Accrued expenses and other liabilities | 6,151 | (791) | |||||
| Deferred revenue | 288 | 492 | |||||
| Customer deposits | 261 | (191) | |||||
| Net cash used in operating activities | (929) | (3,610) | |||||
| Cash flows from investing activities | |||||||
| Purchase of property, plant and equipment | (968) | (385) | |||||
| Additions to internally developed software | (123) | — | |||||
| Net cash used in investing activities | (1,091) | (385) | |||||
| Cash flows from financing activities | |||||||
| Borrowings under secured borrowing facility | — | 37 | |||||
| Principal payments on 2024 Term Loan A Facility | (189) | — | |||||
| Principal payments on 2024 Term Loan B Facility | (552) | — | |||||
| Principal payments on long-term obligations | — | (235) | |||||
| Proceeds from secured credit facility | 1,655 | 976 | |||||
| Principal payments on secured credit facility | (1,356) | ||||||
| Principal payments on finance leases | (8) | (100) | |||||
| Net cash provided by (used in) financing activities | (450) | 678 | |||||
| Effect of exchange rates on cash and cash equivalents | 90 | (87) | |||||
| Net increase (decrease) in cash and cash equivalents | (2,380) | (3,404) | |||||
| Cash and equivalents, beginning of period, including cash from discontinued operations | 12,106 | 6,905 | |||||
| Cash and equivalents, end of period, including cash from discontinued operations | $ | 9,726 | $ | 3,501 | |||
| Supplemental cash flow data: | |||||||
| Income tax payments, net of refunds received | 271 | (16) | |||||
| Interest paid | 928 | 534 | |||||
Schedule 1: Reconciliation of Adjusted EBITDA and constant currency revenues |
|||||||||
| Reconciliation of Non-GAAP Financial Measures to GAAP Measures |
|||||||||
| Non-GAAP constant currency revenue reconciliation | |||||||||
| Three Months ended |
|||||||||
| ($ in thousands) | 2025 |
2024 |
|||||||
| Revenues, as reported (GAAP) | 37,673 |
38,113 | |||||||
| Foreign currency exchange impact(1) | 766 | - | |||||||
| Revenues, at constant currency (Non-GAAP) | 38,438 |
38,113 | |||||||
| Reconciliation of Adjusted EBITDA from Continuing Operations |
|||||||||
| Three Months Ended |
|||||||||
| (dollars in thousands) | 2025 |
2024 |
|||||||
| Net loss from continuing operations | $ | (3,855) | $ | (858) | |||||
| Income tax expense | 762 | 460 | |||||||
| Interest expense including related party interest expense, net | 1,744 | 1,436 | |||||||
| Depreciation and amortization | 627 | 807 | |||||||
| EBITDA from continuing operations | (722) | 1,846 | |||||||
| Restructuring and related expenses(2) | 667 | 332 | |||||||
| Foreign exchange losses, net | (71) | 752 | |||||||
| Stock-based compensation expense(3) | 3,818 | — | |||||||
| Changes in fair value of warrant liability | 2 | (37) | |||||||
| Transaction Fees(4) | — | 49 | |||||||
| Adjusted EBITDA from continuing operations | $ | 3,694 | $ | 2,942 | |||||
(1) Constant currency excludes the impact of foreign currency fluctuations and is computed by applying the average exchange rates for the quarter ended
(2) Adjustment represents costs associated with restructuring, including employee severance and vendor and lease termination costs.
(3) Related to accelerated vesting of RSU and stock awards.
(4) Represents transaction costs incurred as part of the Business Combination.
| Reconciliation of Adjusted EBITDA from Discontinued Operations | |||||||||
| Three Months Ended |
|||||||||
| (dollars in thousands) | 2025 | 2024 |
|||||||
| Net loss from discontinued operations, net of income taxes | $ | (495) | $ | (1,350) | |||||
| Income tax expense | — | — | |||||||
| Interest expense, net | 14 | 10 | |||||||
| Depreciation and amortization | 32 | 150 | |||||||
| EBITDA from discontinued operations | (449) | (1,190) | |||||||
| Foreign exchange losses (gains), net | (359) | 80 | |||||||
| Adjusted EBITDA from discontinued operations | $ | (808) | $ | (1,110) | |||||
Source:

Investor and/or Media Contacts: investors@xbpeurope.com
Source: XBP Europe